Document Preview Unavailable
Loss of AKR1C1 is a good prognostic factor in advanced NPC cases and increases chemosensitivity to cisplatin in NPC cells
Zhou, Chen; Shen, Guowen; Yang, Fan; Duan, Jingling; Wu, Zhen; et al. Journal of Cellular and Molecular Medicine (Online) Vol. 24, Iss. 11, (Jun 1, 2020): 6438-6447.You might have access to this document
-
Try and log in through your institution to see if they have access to the full text.
Log in through your library